Moderna gained over 2% and reached record high_老虎社区_美港股上老虎

Moderna gained over 2% and reached record high

Tiger Newspress2021-08-05

(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose

Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.

That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.

Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.

However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.

CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.

Moderna beat on income and revenue in its Q2 earnings.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

268

Nurol
·2021-08-06
Covid factor
回复
点赞
举报
Williamw
·2021-08-06
Record high
回复
3
举报
收起
- GabrielS:
  help like
  2021-08-06
  回复
  举报
Melvinleong
·2021-08-06
But it dropped shortly after.
回复
2
举报
Dreamchaser9
·2021-08-06
Ok
回复
1
举报
收起
- Boo2bear:
  Pls like
  2021-08-06
  回复
  举报
Jasminephyo
·2021-08-06
Ok
回复
6
举报
收起
- beankim:
  yes
  2021-08-06
  回复
  举报
ALearner
·2021-08-06
Should invest in biotech firm [Miser]
回复
4
举报
收起
- M3Mike:
  Ya, pick the right one.
  2021-08-06
  回复
  举报
lewisleeks
·2021-08-06
Still can up[Miser] [Miser]
回复
1
举报
Newbie_21
·2021-08-06
Expected.. Nice
回复
6
举报
koolgal
·2021-08-06
Moderna will continue to grow as long as there is Covid-19! Which is better to invest - Moderna or Pfizer?
回复
12
举报
收起
- firefirefire:
  both are a good.. this type of pharmaceutical is stable..it holds.
  2021-08-06
  回复
  举报
- koolgal:
  Thanks for sharing 👍😊
  2021-08-06
  回复
  举报
- Gaga71:
  Both
  2021-08-06
  回复
  举报
查看更多 2 条评论
stocksown
·2021-08-06
nice
回复
1
举报
收起
- Ignis:
  good
  2021-08-08
  回复
  举报
pandalinden
·2021-08-06
[暗中观察]
回复
2
举报
来人
·2021-08-06
Nice 👍
回复
2
举报
matwonderboy
·2021-08-06
More vaccination more $
回复
3
举报
replaygoh
·2021-08-06
boom...
回复
3
举报
Jon1234
·2021-08-06
Good please like
回复
2
举报
收起
- stocksown:
  nice
  2021-08-06
  回复
  举报
Jzee
·2021-08-06
Like
回复
2
举报
收起
- Jzee:
  Like
  2021-08-06
  回复
  举报
Troytan
·2021-08-06
💪
回复
1
举报
Evelynqql
·2021-08-05
👍🏻👍🏻
回复
3
举报
choya
·2021-08-05
gd
回复
4
举报
Mml
·2021-08-05
Informative
回复
2
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1106584329?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-05 21:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106584329","market":"us","top_or_hot":-1,"title":"Moderna gained over 2% and reached record high","media":"Tiger Newspress","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n2021-08-05 21:59 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":null,"article_id":"1106584329","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","pubTimestamp":1628171968,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"莫德纳涨超2%，创历史新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":893186071,"gmtCreate":1628246524193,"gmtModify":1633752282220,"author":{"id":"4090704081019170","authorId":"4090704081019170","name":"Nurol","avatar":"https://static.tigerbbs.com/61def0f6503ae7bb4a323ec8ac4d07f0","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Covid factor&nbsp;","listText":"Covid factor&nbsp;","text":"Covid factor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893186071","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899773158,"gmtCreate":1628217763074,"gmtModify":1633752495838,"author":{"id":"3572240910775763","authorId":"3572240910775763","name":"Williamw","avatar":"https://static.tigerbbs.com/ecafced5a6c16b176940098e09cf69b6","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Record high","listText":"Record high","text":"Record high","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899773158","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5445931,"gmtCreate":1628244535895,"gmtModify":1635158537778,"authorId":3576079681958199,"author":{"id":3576079681958199,"authorId":3576079681958199,"name":"GabrielS","avatar":"https://static.tigerbbs.com/db2b1d5dba73d167a691afddd6986348","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899773158,"type":1,"supId":0,"prevId":0,"content":"help like","text":"help like","html":"help like"}],"langContent":"EN"},{"id":899764683,"gmtCreate":1628215997142,"gmtModify":1633752519836,"author":{"id":"4089547170637760","authorId":"4089547170637760","name":"Melvinleong","avatar":"https://static.tigerbbs.com/c77ae67b370b71710abcb7f140ebfe3e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"But it dropped shortly after.&nbsp;","listText":"But it dropped shortly after.&nbsp;","text":"But it dropped shortly after.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899764683","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899700384,"gmtCreate":1628213314548,"gmtModify":1633752565183,"author":{"id":"3581782846197879","authorId":"3581782846197879","name":"Dreamchaser9","avatar":"https://static.tigerbbs.com/f4f8f000953179179078bdd5e6f748b6","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899700384","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5442563,"gmtCreate":1628216407911,"gmtModify":1635158798932,"authorId":3578969648963961,"author":{"id":3578969648963961,"authorId":3578969648963961,"name":"Boo2bear","avatar":"https://static.tigerbbs.com/209ae746c8124fe2d5f79aee784d2fcc","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899700384,"type":1,"supId":0,"prevId":0,"content":"Pls <u>like</u>","text":"Pls <u>like</u>","html":"Pls <u>like</u>"}],"langContent":"EN"},{"id":899529264,"gmtCreate":1628207226658,"gmtModify":1631891926839,"author":{"id":"3585306064379170","authorId":"3585306064379170","name":"Jasminephyo","avatar":"https://static.tigerbbs.com/81aad6a5797d9f136f0438609cb372a5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899529264","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5442629,"gmtCreate":1628216832445,"gmtModify":1635158793042,"authorId":3568042901804000,"author":{"id":3568042901804000,"authorId":3568042901804000,"name":"beankim","avatar":"https://static.tigerbbs.com/7e86bf0ae7dd84473464d6af842304eb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899529264,"type":1,"supId":0,"prevId":0,"content":"yes","text":"yes","html":"yes"}],"langContent":"EN"},{"id":899586759,"gmtCreate":1628206589771,"gmtModify":1633752702163,"author":{"id":"3581627611317712","authorId":"3581627611317712","name":"ALearner","avatar":"https://static.tigerbbs.com/dd4e09038044887c08337f0d263b9446","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Should invest in biotech firm [Miser]&nbsp;","listText":"Should invest in biotech firm [Miser]&nbsp;","text":"Should invest in biotech firm [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899586759","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5444443,"gmtCreate":1628231035655,"gmtModify":1635158642561,"authorId":4088154342981070,"author":{"id":4088154342981070,"authorId":4088154342981070,"name":"M3Mike","avatar":"https://static.tigerbbs.com/259e456faa292a2e09a116698d67ff21","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899586759,"type":1,"supId":0,"prevId":0,"content":"Ya, pick the right one.","text":"Ya, pick the right one.","html":"Ya, pick the right one."}],"langContent":"EN"},{"id":899581034,"gmtCreate":1628206444228,"gmtModify":1633752705258,"author":{"id":"4089010444435920","authorId":"4089010444435920","name":"lewisleeks","avatar":"https://static.tigerbbs.com/d39cf835a09bdd21dce8a780b993940c","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Still can up[Miser]&nbsp;[Miser]&nbsp;","listText":"Still can up[Miser]&nbsp;[Miser]&nbsp;","text":"Still can up[Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899581034","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899517221,"gmtCreate":1628206257563,"gmtModify":1631891002172,"author":{"id":"3581562486795328","authorId":"3581562486795328","name":"Newbie_21","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Expected.. Nice","listText":"Expected.. Nice","text":"Expected.. Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899517221","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899530067,"gmtCreate":1628205518559,"gmtModify":1628205518559,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Moderna will continue to grow as long as there is Covid-19!&nbsp; Which is better to&nbsp; invest - Moderna or Pfizer?&nbsp;","listText":"Moderna will continue to grow as long as there is Covid-19!&nbsp; Which is better to&nbsp; invest - Moderna or Pfizer?&nbsp;","text":"Moderna will continue to grow as long as there is Covid-19! Which is better to invest - Moderna or Pfizer?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/899530067","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5440870,"gmtCreate":1628208375595,"gmtModify":1635158964283,"authorId":3570742778586711,"author":{"id":3570742778586711,"authorId":3570742778586711,"name":"firefirefire","avatar":"https://static.tigerbbs.com/c04f323294e537812b906a523831e3c8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899530067,"type":1,"supId":0,"prevId":0,"content":"both are a good.. this type of pharmaceutical is stable..it holds.","text":"both are a good.. this type of pharmaceutical is stable..it holds.","html":"both are a good.. this type of pharmaceutical is stable..it holds."},{"id":5440936,"gmtCreate":1628208675170,"gmtModify":1635158957854,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899530067,"type":1,"supId":5440870,"prevId":0,"content":"Thanks for sharing 👍😊","text":"Thanks for sharing 👍😊","html":"Thanks for sharing 👍😊"},{"id":5441116,"gmtCreate":1628209438068,"gmtModify":1635158938088,"authorId":3579082097230100,"author":{"id":3579082097230100,"authorId":3579082097230100,"name":"Gaga71","avatar":"https://static.tigerbbs.com/02afa88b95dc30f4a60767c18f9e2f39","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899530067,"type":1,"supId":0,"prevId":0,"content":"Both","text":"Both","html":"Both"},{"id":5441265,"gmtCreate":1628210060981,"gmtModify":1635158921857,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899530067,"type":1,"supId":5441116,"prevId":0,"content":"Thanks. 👍😊","text":"Thanks. 👍😊","html":"Thanks. 👍😊"},{"id":5442273,"gmtCreate":1628214905655,"gmtModify":1635158824442,"authorId":4087351235415740,"author":{"id":4087351235415740,"authorId":4087351235415740,"name":"4e6e78ce","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899530067,"type":1,"supId":0,"prevId":0,"content":"both! and novavax too I <u>feel</u>","text":"both! and novavax too I <u>feel</u>","html":"both! and novavax too I <u>feel</u>"}],"langContent":"EN"},{"id":899592248,"gmtCreate":1628205384084,"gmtModify":1633752729738,"author":{"id":"3581764501240522","authorId":"3581764501240522","name":"stocksown","avatar":"https://static.tigerbbs.com/1cd4b2b2ebfd577c03e2e9db6a1f4277","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"nice&nbsp;","listText":"nice&nbsp;","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899592248","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5459665,"gmtCreate":1628388701545,"gmtModify":1635157319032,"authorId":3574686466924712,"author":{"id":3574686466924712,"authorId":3574686466924712,"name":"Ignis","avatar":"https://static.tigerbbs.com/543d1f3e8b4901fba226eb61e5713bc4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899592248,"type":1,"supId":0,"prevId":0,"content":"good","text":"good","html":"good"}],"langContent":"EN"},{"id":899509814,"gmtCreate":1628204632038,"gmtModify":1633752742859,"author":{"id":"3586673455329010","authorId":"3586673455329010","name":"pandalinden","avatar":"https://static.tigerbbs.com/99a6ec80c08845c333f55bbe9fb4805b","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"[暗中观察]&nbsp;","listText":"[暗中观察]&nbsp;","text":"[暗中观察]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899509814","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":899241536,"gmtCreate":1628203769925,"gmtModify":1633752759202,"author":{"id":"3575544575320394","authorId":"3575544575320394","name":"来人","avatar":"https://static.tigerbbs.com/0af89587decbb8a1d3e1596adc29cb98","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Nice 👍","listText":"Nice 👍","text":"Nice 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899241536","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899262643,"gmtCreate":1628201620082,"gmtModify":1631888861860,"author":{"id":"4089803332706340","authorId":"4089803332706340","name":"matwonderboy","avatar":"https://static.tigerbbs.com/fd90942171b488149ba14766696fd500","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"More vaccination more $","listText":"More vaccination more $","text":"More vaccination more $","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899262643","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899266457,"gmtCreate":1628201564979,"gmtModify":1633752784785,"author":{"id":"3582963095283492","authorId":"3582963095283492","name":"replaygoh","avatar":"https://static.tigerbbs.com/d47b21291424a3d55039334a8de5cdb9","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"boom...","listText":"boom...","text":"boom...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899266457","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899678735,"gmtCreate":1628183832827,"gmtModify":1631889270827,"author":{"id":"3573821645459947","authorId":"3573821645459947","name":"Jon1234","avatar":"https://static.tigerbbs.com/b8152ae43bb8b150654f871f2c6e1a34","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good please like","listText":"Good please like","text":"Good please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899678735","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5440118,"gmtCreate":1628205393094,"gmtModify":1631889270831,"authorId":3581764501240522,"author":{"id":3581764501240522,"authorId":3581764501240522,"name":"stocksown","avatar":"https://static.tigerbbs.com/1cd4b2b2ebfd577c03e2e9db6a1f4277","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899678735,"type":1,"supId":0,"prevId":0,"content":"nice ","text":"nice ","html":"nice "}],"langContent":"EN"},{"id":899653841,"gmtCreate":1628180587483,"gmtModify":1631891343535,"author":{"id":"3582424929463460","authorId":"3582424929463460","name":"Jzee","avatar":"https://static.tigerbbs.com/5468fdd5130cc7553a9184833a1afe6a","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899653841","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5438695,"gmtCreate":1628180597775,"gmtModify":1631891343539,"authorId":3582424929463460,"author":{"id":3582424929463460,"authorId":3582424929463460,"name":"Jzee","avatar":"https://static.tigerbbs.com/5468fdd5130cc7553a9184833a1afe6a","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":899653841,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"},{"id":899624973,"gmtCreate":1628180197992,"gmtModify":1633752848588,"author":{"id":"3571482048865852","authorId":"3571482048865852","name":"Troytan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"💪","listText":"💪","text":"💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899624973","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899633076,"gmtCreate":1628176959495,"gmtModify":1633752879884,"author":{"id":"3578350504021466","authorId":"3578350504021466","name":"Evelynqql","avatar":"https://static.tigerbbs.com/26fc5d52b62cf4d76e72b5ffdb8d9466","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"👍🏻👍🏻","listText":"👍🏻👍🏻","text":"👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899633076","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899876927,"gmtCreate":1628175758169,"gmtModify":1633752898100,"author":{"id":"3585264987238241","authorId":"3585264987238241","name":"choya","avatar":"https://static.tigerbbs.com/bf32f96fd67870273541927f4a6ed9e6","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"gd","listText":"gd","text":"gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899876927","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":899873980,"gmtCreate":1628175650340,"gmtModify":1633752900496,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899873980","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":268,"commentSize":50,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}